Insights Into Ovarian Cancer
Perspectives on current treatment practices in the management of ovarian cancer with regard to molecular testing and first-line and maintenance therapy options
Northwest – December 17, 2020
Faculty Chair
Dan Veljovich, MD
Swedish Cancer Institute, Seattle, WA
REPORT SNAPSHOT
- A moderated, virtual roundtable discussion focusing on the treatment of ovarian cancer was held on December 17, 2020
- Disease state and data presentations were developed in conjunction with Dr Dan Veljovich from Swedish Cancer Institute
- The group of advisors comprised 8 community oncologists who treat patients with ovarian cancer
- Insights on the following therapies were obtained: chemotherapies (platinums, taxanes), olaparib, niraparib, bevacizumab
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection was accomplished through use of audience response system questioning and moderated discussion
- Attendees of the roundtable represented community oncologists from Washington, Wyoming, and California
